摘要
在国际范围内进行临床研究是进入广阔市场的最佳方法，并且成为确保产品对各地居民安全、有效的前提条件。到国外试验产品也有利于发现新的治疗目标多元化的试验将获得更多的结果，这将提高积极产出的潜力，不管它们处于意料之中还是出乎意料之外。
Conducting clinical research on an international scale is the best way to access wider markets and a prerequisite for ensuring a product is safe and effective in a broad population. Testing a product abroad is also good tor discovering new targets for treatments. A more diverse trial will produce more results and this increases the potential for positive outcomes, whether they are predicted or completely unexpected.
